
Biomedical engineer Leyla Soleymani’s team was responsible for the hardware, including the chip that reads the sample.
Researchers at McMaster and Brock universities have created the prototype for a hand-held device to measure a biomarker for cancer, paving the way for home-based cancer monitoring and to improve access to diagnostic testing.
The device works much like the monitors that people with diabetes use to test their blood-sugar levels and could be used in a medical clinic or at home, all without lab work, greatly simplifying the process for testing blood for cancer’s signature.
A user would mix a droplet of blood in a vial of reactive liquid, then place the mixture onto a strip and insert it into a reader. In minutes, the device would measure an antigen that indicates the degree to which cancer is present.
The prototype has been designed to monitor prostate specific antigen (PSA) and the technology can readily be adapted to measure other markers, depending on the form of cancer or other chronic disease.
The ability to collect such information at home would make the daily lives of patients much easier while also generating accurate, shareable, up-to-the-minute results to guide their doctors in shaping care and treatment – all at a lower cost to the health-care system.
The device would also allow patients to continue to monitor their health after treatment.
The prototype was created by a research collaboration led by McMaster’s Leyla Soleymani, a biomedical engineer and Canada Research Chair in Miniaturized Biomedical Devices, and Brock’s Feng Li, an associate professor of chemistry who leads a bioanalytical chemistry lab.
Soleymani’s team (also including Sarah Traynor and Richa Pandey) was responsible for the hardware, including the chip that reads the sample, while Li’s team (also including Guan Wang) created the technology that analyzes the sample.
“This is another step toward truly personalized medicine,” Soleymani says. “We’re getting away from centralized, lab-based equipment for this kind of testing.
“This would make monitoring much more accessible and cut down on the number of times patients need to leave home to provide blood samples.”
Once commercialized, this device will be a paradigm shift for cancer diagnosis and prognosis, Li says.
“Since this device is a lot more accessible and user-friendly than conventional technologies, patients will be more willing to use it, which can improve clinical outcomes and save lives.”
The researchers’ proof-of-concept work is described in an article published in the journal Angewandte Chemie. The invention will need to be tested more broadly before earning the regulatory approvals that would permit commercial manufacturing
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cancer biomarkers
- Ann Arbor-based LynxDx launches non-invasive prostate cancer screening
A new non-invasive prostate cancer screening test was developed based on work by University of Michigan researchers.
- Biomarkers Market Size to Surpass USD 97.51 Billion by 2026 | With 12.1% CAGR
The global Biomarkers Market size stood at USD 39.10 billion in 2018. The market is slated to expand USD 97.51 billion by 2026, exhibiting a CAGR of 12.1% over the ...
- Cancer Biomarkers Market Size 2023 Comprehensive Insights and Capacity Growth Analysis 2028
Pre and Post Covid Report Is Covered | Final Report Will Add the Analysis of the Impact of Russia-Ukraine War and ...
- Cancer Biomarkers Detection Market with Upcoming Trends, Demands, and Business Analysis to 2028
Cancer Biomarkers Detection Market report's in-depth analysis of the restraints shows how they different from drivers ...
- Researchers develop new biomarkers to improve skin cancer detection
New biomarkers to improve skin cancer detection and avoid delays in treatment are being developed by researchers at the University of South Australia.
Go deeper with Google Headlines on:
Cancer biomarkers
[google_news title=”” keyword=”cancer biomarkers” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Cancer biomarker detector
- Cancer Biomarkers Detection Market with Upcoming Trends, Demands, and Business Analysis to 2028
Cancer Biomarkers Detection Market report's in-depth analysis of the restraints shows how they different from drivers ...
- A Simple Urine Test Could Detect Brain Tumors
Researchers in Japan have developed a new device to identify proteins – which are diagnostic biomarkers of brain cancer – in urine. The study is published in ACS Nano.
- Researchers develop new biomarkers to improve skin cancer detection
New biomarkers to improve skin cancer detection and avoid delays in treatment are being developed by researchers at the University of South Australia.
- More accurate biomarkers needed to ensure melanomas are spotted
New biomarkers to improve skin cancer detection and avoid delays in treatment are being developed by researchers at the University of South Australia.
- CRISPR Tech Lights Up Cancer Biomarker miRNAs in Plasma Exosomes
Researchers suggest that this new platform has the potential to make cancer diagnosis and monitoring quicker and easier by analyzing blood samples.
Go deeper with Google Headlines on:
Cancer biomarker detector
[google_news title=”” keyword=”cancer biomarker detector” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]